

Can't get Teriparatide? Learn about effective alternatives like Abaloparatide (Tymlos), Romosozumab (Evenity), Denosumab (Prolia), and bisphosphonates for osteoporosis treatment.
Teriparatide — sold as Forteo and available in generic form — is one of the most effective medications for building new bone in people with severe osteoporosis. But what happens when you can't fill your prescription? Maybe your pharmacy doesn't stock it, your insurance denied coverage, or the cost is simply too high.
The good news is that there are several other FDA-approved osteoporosis medications that your doctor may consider. In this guide, we'll walk through what Teriparatide does, how it works, and the best alternatives available in 2026.
Teriparatide is an injectable medication made from the first 34 amino acids of human parathyroid hormone (PTH). It belongs to a class of drugs called parathyroid hormone analogs and is classified as an osteoanabolic agent — meaning it actively builds new bone rather than simply preventing bone loss.
It's FDA-approved for:
The typical dose is 20 mcg injected subcutaneously once daily using a prefilled pen. Treatment usually lasts up to 2 years.
Most osteoporosis drugs are "antiresorptive" — they slow down the cells that break down bone (osteoclasts). Teriparatide takes a different approach. When given as a brief daily pulse, it stimulates osteoblasts (the cells that build bone), increasing bone mineral density at the spine and hip and significantly reducing fracture risk.
In clinical trials, Teriparatide reduced the risk of new vertebral fractures by 65% and nonvertebral fractures by 53% compared to placebo. That's why it's often reserved for patients with the most severe osteoporosis or those who haven't responded to other treatments.
If you can't get Teriparatide, here are the most common alternatives your doctor might recommend:
Abaloparatide is the closest alternative to Teriparatide. It's also a parathyroid hormone analog (specifically a PTH-related protein analog) that builds new bone through daily subcutaneous injection.
If your main issue is access to Teriparatide specifically, Abaloparatide works through a very similar mechanism and may be more readily available at your pharmacy.
Romosozumab is a newer medication that takes a unique dual approach — it both builds new bone and reduces bone breakdown at the same time. It works by blocking a protein called sclerostin.
Romosozumab is typically followed by an antiresorptive medication (like a bisphosphonate or Denosumab) to maintain the bone gains.
Denosumab works differently from Teriparatide — it's an antiresorptive medication that blocks RANKL, a protein that activates bone-destroying cells. It doesn't build new bone the way Teriparatide does, but it effectively prevents further bone loss and reduces fracture risk.
Bisphosphonates are the first-line treatment for osteoporosis and the most widely prescribed. They slow bone breakdown but don't actively build new bone.
If you haven't tried bisphosphonates yet, your insurance may actually require you to try them before covering Teriparatide. They're effective, well-studied, and far less expensive.
The best alternative depends on your specific situation:
Always talk to your prescriber before switching medications. They can help you weigh the risks and benefits based on your bone density, fracture history, and overall health.
Not being able to get Teriparatide is frustrating — especially when you know it's the medication your doctor recommended. But there are real, effective alternatives available in 2026. Whether it's Abaloparatide for a similar bone-building approach, Romosozumab for a powerful 12-month course, or bisphosphonates for an affordable long-term option, you have choices.
If you're still looking for Teriparatide specifically, try Medfinder to check pharmacy availability near you, or read our guide on how to find Teriparatide in stock. And for help with the cost, check out our savings and patient assistance guide.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.